Manufacturing Expertise

Adherence to established quality standards assures safety and efficacy of drug products.

Production Facilities

The company has multi locational manufacturing sites for producing APIs. The WHO-GMP approved manufacturing facility at Punjab with 17 manufacturing blocks comprises Pilot Plant, dedicated blocks and multi-purpose blocks designed to comply with stringent USFDA and

other regulatory standards.


An API facility in the state of Jammu & Kashmir complying with cGMP requirements.


The company possesses a cumulative reactor capacity of 370 m3, one of the largest in North India. Complex reaction capabilities and stringent controls provide an ideal base for innovative and quality products.

Copyright © 2010 Ind-Swift Laboratories Limited. All rights reserved.

Designned & Developed by Ayushveda Informatics